Anti-transferrin Receptor-Modified Amphotericin B-loaded PLA-PEG Nanoparticles Cure Candidal Meningitis and Reduce Drug Toxicity.

Xiaolong Tang,Yong Liang,Yongqiang Zhu,Chunmei Xie,Aixia Yao,Li Chen,Qinglin Jiang,Tingting Liu,Xiaoyu Wang,Yunyun Qian,Jia Wei,Wenxuan Ni,Jingjing Dai,Zhenyou Jiang,Wei Hou
DOI: https://doi.org/10.2147/ijn.s84656
IF: 7.033
2015-01-01
International Journal of Nanomedicine
Abstract:Fatal fungal infections in central nervous system (CNS) can occur through hematogenous spread or direct extension. At present, hydrophobic amphotericin B (AMB) is the most effective antifungal drug in clinical trials. However, AMB is hydrophobic and therefore penetrates poorly into the CNS, and therapeutic levels of AMB are hard to achieve. The transferrin receptor (TfR/CD71) located at the blood-brain barrier mediates transferrin transcytosis. In order to enhance the receptor-mediated delivery of AMB into CNS with therapeutic level, an anti-TfR antibody (OX26)-modified AMB-loaded PLA (poly[lactic acid])-PEG (polyethylene glycol)-based micellar drug delivery system was constructed. The prepared OX26-modified AMB-loaded nanoparticles (OX26-AMB-NPs) showed significant reduction of CNS fungal burden and an increase of mouse survival time. In conclusion, OX26-AMB-NPs represent a promising novel drug delivery system for intracerebral fungal infection.
What problem does this paper attempt to address?